Friday Links

Expert opinions: Will MFN reduce US drug prices?Robots in maternity care.What drives company decisions on new medicine launches and UK investment?Incorporating dynamic pricing into HEOR models (dynamicpv)Tale of 2 value sets.How to handle the lows? Honesty.Integrity in journalism: Giannis edition.

Read More

Amodei Believes “AI-Enabled Autocracy” Could Be Imminent

By MIKE MAGEE Last month, Dario Amodei, CEO of Anthropic, did it again – scaring the bejesus out of societal leaders worldwide with warnings that their grip on security and governance of human populations is dangerously close to AI extinction. Amodei’s opening paragraph in his article titled “The Adolescence of Technology” wastes no time getting the reader’s…

Read More

COO of Mayo Clinic Platform Believes De-identified Data Leads to Loss of Utility for Pharma, Other Third Parties

Mayo Clinic has about 100 petabytes of structured and unstructured EHR data, and about 28 petabytes have been de-identified, but in the Mayo Clinic way. Now that data capability is being combined with institutional expertise to provide a compelling case for pharma companies looking to leverage data, AI and provider expertise in drug development The…

Read More